Aprogen Medicines Inc.

KOSE:A007460 Voorraadrapport

Marktkapitalisatie: ₩317.2b

Aprogen Medicines Beheer

Beheer criteriumcontroles 0/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Ki-Cheol Lim

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEOno data
Eigendom CEOn/a
Management gemiddelde ambtstermijngeen gegevens
Gemiddelde ambtstermijn bestuurgeen gegevens

Recente managementupdates

Recent updates

Aprogen Medicines Inc. (KRX:007460) May Have Run Too Fast Too Soon With Recent 25% Price Plummet

Sep 29
Aprogen Medicines Inc. (KRX:007460) May Have Run Too Fast Too Soon With Recent 25% Price Plummet

Is Aprogen Medicines (KRX:007460) Using Too Much Debt?

Aug 22
Is Aprogen Medicines (KRX:007460) Using Too Much Debt?

Aprogen Medicines Inc. (KRX:007460) Stock Rockets 41% As Investors Are Less Pessimistic Than Expected

Jul 21
Aprogen Medicines Inc. (KRX:007460) Stock Rockets 41% As Investors Are Less Pessimistic Than Expected

Aprogen Medicines Inc.'s (KRX:007460) 25% Share Price Plunge Could Signal Some Risk

May 31
Aprogen Medicines Inc.'s (KRX:007460) 25% Share Price Plunge Could Signal Some Risk

Is Aprogen Medicines (KRX:007460) A Risky Investment?

May 21
Is Aprogen Medicines (KRX:007460) A Risky Investment?

Aprogen Medicines Inc. (KRX:007460) Investors Are Less Pessimistic Than Expected

Feb 26
Aprogen Medicines Inc. (KRX:007460) Investors Are Less Pessimistic Than Expected

If You Had Bought Aprogen KIC's (KRX:007460) Shares Three Years Ago You Would Be Down 86%

Jan 07
If You Had Bought Aprogen KIC's (KRX:007460) Shares Three Years Ago You Would Be Down 86%

CEO

Ki-Cheol Lim (78 yo)

no data

Tenure

Ki-Cheol Lim serves as the Chief Executive Officer of Aprogen Medicines Inc. (formerly known as Aprogen KIC Inc.) and serves as its Director and also served as Vice President. Ki-Cheol Lim also served at D...